Kiran Vyapar’s INR 50 Crores Loan Facility to Drawbridge Ventures

Khaitan & Co advised Kiran Vyapar Limited on the deal.

Kiran Vyapar Limited executed its Rupee term loan facility for an amount of INR 50 Crores to Drawbridge Ventures Private Limited for the purpose of acquiring equity shares of Sarvejana Healthcare Private Limited from India Life Sciences Fund II LLC. The term loan facility was inter alia secured by pledge over equity shares of Drawbridge Ventures Private Limited and Sarvejana Healthcare Private Limited. Further, a corporate guarantee and personal guarantee was provided in relation to the term loan facility.  

Kiran Vyapar Ltd is engaged in the business of investments, trading and dealing in shares and securities, mutual funds, and financing. The Company operates in India.

The Khaitan & Co team consisted of Partner Kumar Saurabh Singh (Picture), Rahul Chakraborti (Partner), Savni Tewari (Senior Associate), Karishma Singh (Senior Associate), Saumya Agarwal (Associate).

Involved fees earner: Saumya Agarwal – Khaitan & Co.; Rahul Chakraborti – Khaitan & Co.; Kumar Saurabh Singh – Khaitan & Co.; Karishma Singh – Khaitan & Co.; Savni Tewari – Khaitan & Co.;

Law Firms: Khaitan & Co.;

Clients: Kiran Vyapar Limited;

Author: Sonia Carcano